SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Stock Attack II - A Complete Analysis
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Gersh Avery who wrote (52211)10/9/2006 9:45:13 AM
From: Casaubon  Read Replies (1) of 52237
 
Gersh try to get in a VX-950 clinical trial or wait a few months and see if the drug gets FDA approval. The drug induces very rapid viral clearance in early clinical trials. Really the only question remaining is SVR (sustained viral response), after discontinuation of the regimen.

Good Luck!

hcvadvocate.org

PS your liver can start to repair itself once you've cleared the virus!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News